Pluristem Market Cap ($34.49 Million)
Market Cap & Net Worth: Pluristem (PSTI)
Pluristem market cap. Pluristem (TA:PSTI) has a market capitalization of $34.49 Million (ILA12.86 Billion) as of October 31, 2026. Listed on the TA stock exchange, this Israel-based company holds position #23103 globally and #319 in its home market, demonstrating a 41.03% increase in market value over the past year.
Market capitalization, also known as net worth in stock markets, is calculated by multiplying Pluristem's stock price ILA397.70 by its total outstanding shares 32347600 (32.35 Million).
Pluristem Market Cap History (2015–2026)
Pluristem market cap history from 2015 to 2026. Data shows change from $3.90 Billion to $34.49 Million (-37.24% CAGR). Check Pluristem stock price for real-time trading data and today's change.
Pluristem Market Cap to Earnings & Revenue Ratios Timeline
This chart shows how Pluristem's valuation ratios have evolved. The Price to Sales (P/S) ratio compares market cap to revenue, while the Price to Earnings (P/E) ratio compares market cap to net income. Lower values may indicate a more undervalued company relative to its financial performance. Also see Pluristem (PSTI) cash flow conversion for how efficiently the company converts equity into cash flow.
Latest Price to Sales (P/S) Ratio
8559.16x
Pluristem's market cap is 8559.16 times its annual revenue
Latest Price to Earnings (P/E) Ratio
N/A
P/E ratio not applicable due to negative or zero earnings
What These Ratios Tell Investors:
- Price to Sales (P/S) Ratio: Shows how much investors are paying for each dollar of the company's sales. Lower P/S ratios may indicate undervaluation.
- Price to Earnings (P/E) Ratio: Shows how much investors are paying for each dollar of the company's earnings. This is one of the most common valuation metrics.
- Trends in these ratios over time can indicate changing investor sentiment about the company's future growth prospects.
- Industry comparison provides context for whether the company is valued higher or lower than peers.
| Year | Market Cap (USD) | Revenue (USD) | Net Income (USD) | P/S Ratio | P/E Ratio |
|---|---|---|---|---|---|
| 2015 | $3.90 Billion | $379.00K | -$24.68 Million | 10296.90x | N/A |
| 2016 | $4.82 Billion | $2.85 Million | -$23.25 Million | 1693.94x | N/A |
| 2018 | $2.47 Billion | $50.00K | -$26.13 Million | 49431.99x | N/A |
| 2019 | $118.55 Million | $54.00K | -$35.31 Million | 2195.37x | N/A |
| 2020 | $196.86 Million | $23.00K | -$29.15 Million | 8559.16x | N/A |
Competitor Companies of PSTI by Market Capitalization
Companies near Pluristem in the global market cap rankings as of October 31, 2026. See Pluristem balance sheet quality to understand what proportion of total assets are financed by equity.
Key companies related to Pluristem by market ranking:
- Peptron Inc (KQ:087010): Ranked #8734 globally with a market cap of $958.68 Million USD ( ₩1.41 Trillion KRW).
- Bioneer Corporation (KQ:064550): Ranked #18937 globally with a market cap of $101.98 Million USD ( ₩150.48 Billion KRW).
- Panagene Inc (KQ:046210): Ranked #23921 globally with a market cap of $27.42 Million USD ( ₩40.46 Billion KRW).
- MEDIPOST Co. Ltd (KQ:078160): Ranked #19665 globally with a market cap of $84.32 Million USD ( ₩124.42 Billion KRW).
| Rank | Company | Symbol | Market Cap | Price |
|---|---|---|---|---|
| #8734 | Peptron Inc | KQ:087010 | $958.68 Million | ₩92300.00 |
| #18937 | Bioneer Corporation | KQ:064550 | $101.98 Million | ₩6810.00 |
| #23921 | Panagene Inc | KQ:046210 | $27.42 Million | ₩1259.00 |
| #19665 | MEDIPOST Co. Ltd | KQ:078160 | $84.32 Million | ₩8090.00 |
Market Capitalization of Pluristem (2015–2026)
Market capitalization of Pluristem from 2015 to today. Between 2015 and today, Pluristem's market cap moved from $3.90 Billion to $ 34.49 Million, with a yearly change of -37.24%.
| Year | Market Cap | Change (%) |
|---|---|---|
| 2026 | ILA34.49 Million | -58.43% |
| 2025 | ILA82.98 Million | -38.98% |
| 2024 | ILA135.98 Million | +668.25% |
| 2023 | ILA17.70 Million | -39.44% |
| 2022 | ILA29.23 Million | -28.74% |
| 2021 | ILA41.01 Million | -79.17% |
| 2020 | ILA196.86 Million | +66.06% |
| 2019 | ILA118.55 Million | -95.20% |
| 2018 | ILA2.47 Billion | -39.94% |
| 2017 | ILA4.11 Billion | -14.67% |
| 2016 | ILA4.82 Billion | +23.58% |
| 2015 | ILA3.90 Billion | -- |
End of Day Market Cap According to Different Sources
On Oct 31st, 2026 the market cap of Pluristem was reported to be:
| Source | Market Cap |
|---|---|
| Yahoo Finance | $34.49 Million USD |
| MoneyControl | $34.49 Million USD |
| MarketWatch | $34.49 Million USD |
| marketcap.company | $34.49 Million USD |
| Reuters | $34.49 Million USD |
Market cap values may vary slightly between sources due to differences in calculation methods, timing, and data refresh rates.
About Pluristem
Pluri Inc., a biotechnology company, focuses on the development of placenta-based cell therapy product candidates for the treatment of multiple inflammatory, muscle injuries, and hematologic conditions. The company develops placental expanded (PLX) based cell therapy products, including PLX-PAD that is in Phase III clinical trials for the muscle recovery after surgery for hip fracture; in Phase I… Read more